Related Experiment Videos

New approaches to clinical and postmortem investigations of cholinergic mechanisms

A Nordberg¹, A Adem, L Nilsson-Håkansson

¹Department of Pharmacology, Uppsala University, Stockholm, Sweden.

Progress in Brain Research

|January 1, 1990

Abstract

No abstract available in PubMed .

Related Concept Videos

Articles linked to this work by shared authors, journal, and citation graph.

The validation status of blood biomarkers of amyloid and phospho-tau assessed with the 5-phase development framework for AD biomarkers.

European journal of nuclear medicine and molecular imaging·2021

2020 update on the clinical validity of cerebrospinal fluid amyloid, tau, and phospho-tau as biomarkers for Alzheimer's disease in the context of a structured 5-phase development framework.

European journal of nuclear medicine and molecular imaging·2021

Clinical validity of increased cortical uptake of [18F]flortaucipir on PET as a biomarker for Alzheimer's disease in the context of a structured 5-phase biomarker development framework.

European journal of nuclear medicine and molecular imaging·2021

Regional binding of tau and amyloid PET tracers in Down syndrome autopsy brain tissue.

Molecular neurodegeneration·2020

Longitudinal changes of tau PET imaging in relation to hypometabolism in prodromal and Alzheimer's disease dementia.

Molecular psychiatry·2017

Preclinical evaluation of radiation and systemic, RGD-targeted, adeno-associated virus phage-TNF gene therapy in a mouse model of spontaneously metastatic melanoma.

Cancer gene therapy·2016

See all related articles